322 related articles for article (PubMed ID: 36246388)
1. Advances in the application of 3D tumor models in precision oncology and drug screening.
Guan X; Huang S
Front Bioeng Biotechnol; 2022; 10():1021966. PubMed ID: 36246388
[TBL] [Abstract][Full Text] [Related]
2. Tumor organoids: From inception to future in cancer research.
Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
[TBL] [Abstract][Full Text] [Related]
3. Liver organoids and their application in liver cancer research.
Song X; Hou K; Zhou H; Yang J; Cao T; Zhang J
Regen Ther; 2024 Mar; 25():128-137. PubMed ID: 38226058
[TBL] [Abstract][Full Text] [Related]
4. [Advances in three-dimensional tumor models for colorectal cancer].
Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
[TBL] [Abstract][Full Text] [Related]
5. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
6. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
7. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
8. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.
Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH
Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421
[TBL] [Abstract][Full Text] [Related]
9. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
10. The role of organoids in cancer research.
Fang Z; Li P; Du F; Shang L; Li L
Exp Hematol Oncol; 2023 Aug; 12(1):69. PubMed ID: 37537666
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
12. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
13. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
Cao J; Chan WC; Chow MSS
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
[TBL] [Abstract][Full Text] [Related]
14. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
15. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
van Rijt A; Stefanek E; Valente K
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
18. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
19. In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models.
Lee SY; Koo IS; Hwang HJ; Lee DW
SLAS Discov; 2023 Jun; 28(4):119-137. PubMed ID: 36997090
[TBL] [Abstract][Full Text] [Related]
20. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
